|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
5
|
|
pubmed:dateCreated |
2006-10-6
|
|
pubmed:abstractText |
The purpose of this phase II study was to prospectively determine the efficacy of preoperative chemoradiation with a hyperfractionated (Hfx) RT boost to 61.8 Gy in locally advanced rectal cancer.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Oct
|
|
pubmed:issn |
1537-453X
|
|
pubmed:author |
pubmed-author:CoiaLawrenceL,
pubmed-author:CooperHarryH,
pubmed-author:DiratzouianHasmikH,
pubmed-author:EisenbergBurtonB,
pubmed-author:FreedmanGaryG,
pubmed-author:HanlonAlexandraA,
pubmed-author:HoffmanJohnJ,
pubmed-author:KisterDebraD,
pubmed-author:KonskiAndreA,
pubmed-author:LancianoRachelleR,
pubmed-author:MeropolNeal JNJ,
pubmed-author:MovsasBenjaminB,
pubmed-author:SigurdsonElinE,
pubmed-author:SteinJoanneJ,
pubmed-author:WeinerLouis MLM
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
29
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
435-41
|
|
pubmed:meshHeading |
pubmed-meshheading:17023775-Adenocarcinoma,
pubmed-meshheading:17023775-Adult,
pubmed-meshheading:17023775-Aged,
pubmed-meshheading:17023775-Aged, 80 and over,
pubmed-meshheading:17023775-Antimetabolites, Antineoplastic,
pubmed-meshheading:17023775-Combined Modality Therapy,
pubmed-meshheading:17023775-Dose Fractionation,
pubmed-meshheading:17023775-Fluorouracil,
pubmed-meshheading:17023775-Humans,
pubmed-meshheading:17023775-Middle Aged,
pubmed-meshheading:17023775-Prospective Studies,
pubmed-meshheading:17023775-Radiotherapy, High-Energy,
pubmed-meshheading:17023775-Rectal Neoplasms,
pubmed-meshheading:17023775-Survival Analysis
|
|
pubmed:year |
2006
|
|
pubmed:articleTitle |
Phase II trial of preoperative chemoradiation with a hyperfractionated radiation boost in locally advanced rectal cancer.
|
|
pubmed:affiliation |
Henry Ford Health System, Radiation Oncology, Detroit, MI 48202, USA. bmovsas1@hfhs.org
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial, Phase II
|
